Teleflex

Heritage Capital Group Appoints Joseph Lemieux, Jr. and Oren Schmidt to Lead Aerospace and Defense Industry Team

Retrieved on: 
Tuesday, April 9, 2024
Teleflex, University of Chicago, Growth, A&D, MRO, Acquisition, University, NYU, Westfield State University, MBA, Marmon Group, Heritage, Long Island University, FINRA, Berkshire Hathaway, Management

Their extensive experience will enhance Heritage Capital Group's capabilities in the A&D sector.

Key Points: 
  • Their extensive experience will enhance Heritage Capital Group's capabilities in the A&D sector.
  • Joseph brings over 27 years of leadership in the A&D industries, starting his career in business development at Teleflex Inc. in 1997.
  • He later co-founded Aero-Hose, Corp., a niche value-added manufacturing company focused on fluid conveyance assemblies across commercial, military, and space markets.
  • Heritage Capital Group is a FINRA registered broker-dealer, and a member of Oaklins, the world's most experienced mid-market M&A advisor, with 850 professionals globally and dedicated industry teams in 45 countries worldwide.

Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)

Retrieved on: 
Thursday, March 14, 2024
Class Action Lawsuit, Professional Services, Legal, Teleflex, GPM, TFX, Helmsley Building, Suite

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.

Key Points: 
  • Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors’ and officers’ possible violations of state laws.
  • If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20240314529066/en/

Ceribell Appoints Sean Manni as Senior Vice President of Sales

Retrieved on: 
Tuesday, April 2, 2024
EEG, Omnicell, Growth, GSK plc, Patient, Senior, Bachelor, Teleflex

SUNNYVALE, Calif., April 2, 2024 /PRNewswire/ -- Today, Ceribell, Inc.®, the developer of the first AI-powered point-of-care EEG diagnostic system, announced the appointment of Sean Manni as Senior Vice President of Sales. In this role, Mr. Manni will lead Ceribell's commercial sales organization as it continues to expand its U.S. footprint.

Key Points: 
  • SUNNYVALE, Calif., April 2, 2024 /PRNewswire/ -- Today, Ceribell, Inc.®, the developer of the first AI-powered point-of-care EEG diagnostic system, announced the appointment of Sean Manni as Senior Vice President of Sales.
  • In this role, Mr. Manni will lead Ceribell's commercial sales organization as it continues to expand its U.S. footprint.
  • "Joining Ceribell represents a unique opportunity to collaborate with an exceptional leadership and sales team," said Manni.
  • Most recently, he served as Vice President, North America Sales at Omnicell, a healthcare service company.

Global Medical Metal Tubing Market to Reach $1,161.9 Million, by 2030 at 7.4% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, March 26, 2024
Geography, Growth, Prevalence, Application, Risk, Conditional sentence, Ametek, Stainless steel, Teleflex, Originality, OEM, Infection, Dialysis, Precision, Catheter, VPS, Administration, Medical device

The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.

Key Points: 
  • The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4052
    Advancements in technology, such as the development of biocompatible and antimicrobial medical metal tubing, are further propelling the growth of the medical metal tubing market.
  • Additionally, the increasing adoption of minimally invasive surgeries and the rising demand for precision medical devices are creating lucrative opportunities for the medical metal tubing market.
  • In conclusion, the medical metal tubing market is experiencing considerable growth due to the growing demand for medical metal tubing in the healthcare sector and advancements in technology driving market growth.

Global Medical Metal Tubing Market to Reach $1,161.9 Million, by 2030 at 7.4% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, March 26, 2024
Geography, Growth, Prevalence, Application, Risk, Conditional sentence, Ametek, Stainless steel, Teleflex, Originality, OEM, Infection, Dialysis, Precision, Catheter, VPS, Administration, Medical device

The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.

Key Points: 
  • The medical metal tubing market is expected to witness significant growth during the forecast period due to the growing demand for medical metal tubing in the healthcare sector.
  • Buy this Complete Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4052
    Advancements in technology, such as the development of biocompatible and antimicrobial medical metal tubing, are further propelling the growth of the medical metal tubing market.
  • Additionally, the increasing adoption of minimally invasive surgeries and the rising demand for precision medical devices are creating lucrative opportunities for the medical metal tubing market.
  • In conclusion, the medical metal tubing market is experiencing considerable growth due to the growing demand for medical metal tubing in the healthcare sector and advancements in technology driving market growth.

Teleflex Announces Quarterly Dividend

Retrieved on: 
Thursday, February 22, 2024
TFX, Teleflex

WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.

Key Points: 
  • WAYNE, Pa., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.
  • The dividend is payable March 15, 2024, to shareholders of record at the close of business on March 1, 2024.
  • Additional information about Teleflex can be obtained from the company’s website at teleflex.com .

Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference

Retrieved on: 
Tuesday, February 20, 2024
TFX, Teleflex, Conference

WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).

Key Points: 
  • WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).
  • A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com .

Elevage Medical Technologies Continues Expansion of Investment Team and Board

Retrieved on: 
Tuesday, February 27, 2024
Frazier Healthcare Partners, Teleflex, Investment, Biological engineering, Mechanical, MIT, Invention, Growth, National academy, MBA, Senior advisor, Revelation, Biomedicine, Mechanical engineering, Patent, Bard (company), Needham & Company, Yale University, Acclarent, Medtronic, Columbia University, American Institute, Management

AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.

Key Points: 
  • hires –
    AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ -- Elevage Medical Technologies ("Elevage"), a portfolio company of Patient Square Capital , dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board.
  • Vice-Presidents Suchira Sharma and Peter Tortora join the Elevage investment team, along with Dr. Josh Makower, a Senior Advisor to Patient Square and Elevage, who will also join the Elevage Board of Directors.
  • Dr. Evan Melrose, CEO of Elevage Medical, said, "We are thrilled with these three key additions to the Elevage team.
  • Dr. Makower is also the Founder & Executive Chairman of ExploraMed, a medical device incubator that has created eleven companies since 1995.

GT Medical Technologies, Inc. Names Per Langoe As CEO

Retrieved on: 
Tuesday, February 20, 2024
Teleflex, Randomized controlled trial, Physician, FDA, Growth, Seed, Health, Medtech, Patient, Oncology, Radiation, Cancer, Brain, Per, Medical imaging

TEMPE, Ariz., Feb. 20, 2024 /PRNewswire/ -- GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced that Per Langoe, a proven industry leader with in-depth radiation oncology experience has joined the company as CEO.

Key Points: 
  • TEMPE, Ariz., Feb. 20, 2024 /PRNewswire/ -- GT Medical Technologies, Inc. (GT MedTech), a medical device company with a corporate purpose of improving the lives of patients with brain tumors, today announced that Per Langoe, a proven industry leader with in-depth radiation oncology experience has joined the company as CEO.
  • said Per Langoe, CEO of GT Medical Technologies.
  • Most recently, Mr. Langoe was the co-founder, President and CEO of Palette Life Sciences, a fully-integrated global life sciences company dedicated to improving patient outcomes.
  • Mr. Langoe succeeds Matt Likens, the founding CEO of GT MedTech who retired in January 2024, continuing the company's significant growth strategy and leadership in advancing GammaTile adoption.

Dave Amerson and Tyler Binney Add Their Experience Commercializing Disruptive Technologies to Intrinsic Therapeutics' Board of Directors

Retrieved on: 
Tuesday, February 13, 2024
Earnout, Acquisition, Intrinsic and extrinsic properties, Boston Scientific, Teleflex, Argosy University, FDA, Marketing, Growth, Johnson & Johnson, University, Therapy, Management

"We are thrilled to welcome these two highly regarded industry leaders to our board," said Cary Hagan, President and CEO.

Key Points: 
  • "We are thrilled to welcome these two highly regarded industry leaders to our board," said Cary Hagan, President and CEO.
  • "Dave and Tyler bring a wealth of experience in launching disruptive technologies and developing high-growth companies and will provide invaluable guidance as we aggressively expand our sales activities this year.
  • With these board additions, Intrinsic is well-positioned to rapidly increase patient access to Barricaid."
  • Dave Amerson served as President and CEO of NeoTract, Inc. until its acquisition by Teleflex in 2017 for $1.1 billion.